Clinical Trial

A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following injection of repeated once-daily doses of ZLP.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-29; most recent amendment 2026-03-19.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT06961747
Lead Sponsor UCB Biopharma SRL
Conditions Healthy Participants
Enrollment 15 participants
Start Date 2025-07-09
Primary Completion 2027-03-23 (estimated)
Study Completion 2027-03-23 (estimated)
Updated on ClinicalTrials.gov 2026-03-24